Economics and capital · Exits liquidity
OpenAI Acquires Orchestra Bio For Drug Development
OpenAI acquired Orchestra Bio and plans to integrate its team and technology into Rosalind and the Rosalind Workbench for life-sciences research.
Read the original at x.comOpens the publisher's site in a new tabAlso covering this
OpenAI acquires Orchestra Bioopenai.com, Oct 20OpenAI acquires startup Orchestra Bio to beef up its biotech businesstechcrunch.com, Oct 20OpenAI Buys Drug Development Company Orchestra Bio — The Informationtheinformation.com, Oct 20Exclusive: OpenAI has acquired Orchestra Bioaxios.com, Oct 20OpenAI acquires startup Orchestra Bio to beef up its biotech business | TechCrunchtechcrunch.com, Oct 20OpenAI acquires Orchestra Bio to build AI agents that speed up drug developmentthe-decoder.com, Oct 21OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Workfinance.yahoo.com, Oct 20OpenAI acquires Orchestra Bio in AI push for new drugs (OPENAI:Private) | Seeking Alphaseekingalpha.com, Oct 20